Induction of peroxisomal lipid metabolism in mice fed a high-fat diet

Molecular Medicine Reports

Volumn 4, Issue 6, 2011, Pages 1157-1162

  Kozawa, Sachi ^a,b   Honda, Ayako ^a   Kajiwara, Naomi ^a   Takemoto, Yasuhiko ^a   Nagase, Tomoko ^a   Nikami, Hideki ^a   Okano, Yukio ^a   Nakashima, Shigeru ^b   Shimozawa, Nobuyuki ^a  

^a GIFU UNIVERSITY   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Obesity; Peroxisomal beta oxidation; Very long chain fatty acids

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER ADRENOLEUKODYSTROPHY 1; ABC TRANSPORTER ADRENOLEUKODYSTROPHY 2; ADIPONECTIN; ADIPONECTIN RECEPTOR 2; ELONGATION FACTOR; FATTY ACID SYNTHASE; HYDROXYSTEROID 17 BETA DEHYDROGENASE 4; LEPTIN; LEPTIN RECEPTOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PLASMALOGEN; RETINOID X RECEPTOR ALPHA; SATURATED FATTY ACID; STEROL CARRIER PROTEIN 2; STEROL REGULATORY ELEMENT BINDING PROTEIN; TESTOSTERONE 17BETA DEHYDROGENASE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2; UNSATURATED FATTY ACID; VERY LONG CHAIN FATTY ACID;

ANIMAL EXPERIMENT; ARTICLE; DISORDERS OF PEROXISOMAL FUNCTIONS; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FEMALE; GENE CONTROL; GENE EXPRESSION; LIPID DIET; LIPID METABOLISM; MOUSE; NONHUMAN; OBESITY; PEROXISOMAL LIPID METABOLISM; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; REGULATOR GENE; UPREGULATION; WEIGHT GAIN;

17-HYDROXYSTEROID DEHYDROGENASES; ACETYLTRANSFERASES; ADIPONECTIN; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CARRIER PROTEINS; DIET, HIGH-FAT; ENOYL-COA HYDRATASE; FATTY ACIDS; FEMALE; LEPTIN; LIPID METABOLISM; MICE; MICE, INBRED C57BL; MULTIENZYME COMPLEXES; PEROXISOMES; PPAR ALPHA;

MUS;

EID: 80053126424     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.560     Document Type: Article

References (17)

1. Shimozawa N: Molecular and clinical aspects of peroxisomal diseases. J Inherit Metab Dis 30: 193-197, 2007.
2. Reddy JK and Hashimoto T: Peroxisomal β-oxidation and peroxisome proliferator-activated receptor a: an adaptive metabolic system. Annu Rev Nutr 21: 193-230, 2001. (Pubitemid 32695270)
3. Hostetler HA, Kier AB and Schroeder F: Very-long-chain and branched-chain fatty acyl-CoAs are high affinity ligands for the peroxisome proliferator-activated receptor α (PPARa). Biochemistry 45: 7669-7681, 2006. (Pubitemid 43894957)
4. Patsouris D, Reddy JK, Müller M and Kersten S: fPeroxisome proliferator-activated receptor a mediates the effects of high-fat diet on hepatic gene expression. Endocrinology 147: 1508-1516, 2006. (Pubitemid 43244386)
5. Pyper SR, Viswakarma N, Jia Y, Zhu YJ, Fondell JD and Reddy JK: PRIC295. A nuclear receptor coactivator, identified from PPAR-α interacting cofactor complex. PPAR Res: Sep 5, 2010 (E-pub ahead of print).
6. Takemoto Y, Suzuki Y, Horibe R, Shimozawa N, Wonders RJ and Kondo N: Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders. Brain Dev 27: 481-487, 2003. (Pubitemid 37485654)
7. Wanders RJ, Vreken P, Ferdinandusse S, et al: Peroxisomal fatty acid a- and β-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases. Biochem Soc Trans 2: 250-267, 2001. (Pubitemid 32587514)
8. Fruchart JC: Peroxisome proliferator-activated receptor-a (PPARα): at the crossroads of obesity, diabetes and cardiovascular disease. Atherosclerosis 205: 1-8, 2009.
9. Liu LX, Janvier K, Berteaux-Lecellier V, Cartier N, Benarous R and Aubourg P: Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters. J Biol Chem 12: 32738-32743, 1999. (Pubitemid 129535304)
10. Weinhofer I, Kunze M, Rampler H, et al: Distinct modulatory roles for thyroid hormone receptors TRα and TRβ in SREBP1-activated ABCD2 expression. Eur J Cell Biol 87: 933-945, 2008.
11. Tamura K, Makino A, Hullin-Matsuda F, et al: Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism. Cancer Res 69: 8133-8140, 2009.
12. Brolinson A, Fourcade S, Jakobsson A, Pujol A and Jacobsson A: Steroid hormones control circadian Elovl3 expression in mouse liver. Endocrinology 149: 3158-3166, 2008. (Pubitemid 351724496)
13. Furukawa S, Fujita T, Shimabukuro M, et al: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114: 1752-1761, 2004. (Pubitemid 40385531)
14. Morrison CD, Huypens P, Stewart LK and Gettys TW: Implications of crosstalk between leptin and insulin signaling during the development of diet-induced obesity. Biochim Biophys Acta 1792: 409-416, 2009.
15. Kadowaki T and Yamauchi T: Adiponectin and adiponectin receptors. Endocr Rev 26: 439-451, 2005. (Pubitemid 40686653)
16. Pessayre D, Fromenty B and Mansouri A: Mitochondrial injury in steatohepatitis. Eur J Gastroenterol Hepatol 16: 1095-1105, 2004. (Pubitemid 39488778)
17. Sharma N, Okere IC, Duda MK, Chess DJ, O'Shea KM and Stanley WC: Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy. Cardiovasc Res 73: 257-268, 2007. (Pubitemid 44937701)